Endothelial cell tube formation (null)

Endothelial cell tubular formation is the process by which endothelial cells connect, migrate, align, and differentiate on a specialized extracellular matrix (such as Matrigel or collagen) to create capillary-like, tube-shaped networks[3][4][6]. This process recapitulates key steps of angiogenesis, the physiologic formation of new blood vessels from pre-existing ones, which is essential for development, tissue growth, wound healing, and plays pathogenic roles in cancer, eye diseases, autoimmune disorders, and cardiovascular disease[1][5][7]. Tube formation is driven by complex molecular signaling, most prominently involving integrins, cytoskeletal regulators (like Rho family GTPases, especially Rac), and pro-angiogenic factors. Tube formation can be inhibited pharmacologically by drugs that target the microtubule or signaling pathways, with paclitaxel and combretastatin A as notable examples[2]. Due to its relevance to disease, tube formation is a readout in assays used to screen angiogenesis modulators or to study vessel biology. However, it is an experimental model of a cellular phenotype, not a discrete druggable target, and thus is not classified as a molecular therapeutic target.

Other names

Tube formation assayCapillary morphogenesisEndothelial tubular morphogenesis

Inhibition of microtubule dynamics; Inhibition of PI3K/Akt signaling pathway; Modulation of matrix-integrin-cytoskeletal signaling axis